Formerly EACHRA, MFU works to promote economic inclusion, create safe spaces, and enhance healthcare access for those facing marginalization in Uganda.
BREAKING: Uganda's National Drug Authority has just approved Lenacapavir, a twice-yearly dose PrEP manufactured by Gilead, a USA based company! This is a game-changer for HIV prevention, especially for those at high risk. This is great step towards ending AIDS by 2030.
Our last panel was about Employability & Homelessness titled “Employability of marginalised youth in Uganda”our appreciation goes to the panelists Winfed Mugambwa @Rights4Her1 Trevor Mukisa @MuntuFoundation Ruby Loretta @DiverseEmpower John Grace Tenywa @MinorityShelter 🙏🏾🥰